Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma

Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma

Abstract Background In this study, we report the follow‐up results of reduced dose of craniospinal radiotherapy (CSRT) followed by tandem high‐dose chemotherapy (HDCT) in patients with high‐risk medulloblastoma (MB). Methods Newly diagnosed high‐risk MB patients (metastatic disease, postoperative re...

Full description

Bibliographic Details
Main Authors: Ji Won Lee, Do Hoon Lim, Ki Woong Sung, Hee Won Cho, Hee Young Ju, Ju Kyung Hyun, Keon Hee Yoo, Hong Hoe Koo, Yeon‐Lim Suh, Yoo‐Sook Joung, Hyung Jin Shin
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Cancer Medicine
Subjects:
craniospinal radiotherapy
high‐dose chemotherapy
long‐term follow‐up
medulloblastoma
treatment‐related mortality
Online Access:https://doi.org/10.1002/cam4.3199

Internet

https://doi.org/10.1002/cam4.3199

Similar Items